CorMedix

 

Home About CorMedix Pipeline News Investor Relations Contact Us
CorMedix

Recent News

12/30/11
CorMedix Provides Year End 2011 Update

11/28/11
CorMedix Appoints Pharmaceutical Veteran, Matthew Duffy to Board of Directors

11/10/11
CorMedix Reports Third Quarter 2011 Results

10/7/11
CorMedix to Host Conference Call on Recent Developments

Cormedix


CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that develops and seeks to commercialize therapeutic products for the treatment of cardiac and renal dysfunction, also known as Cardiorenal disease. Specifically, our goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications – in effect, "Treating the kidney to treat the heart.

Our therapeutic candidates for cardiorenal disease may be small molecules, biologicals, devices and/or diagnostics (tests) that enable therapy.

Listen to what a key opinion leader has to say.

Click here to listen to a key opinion leader commenting on catheter related bloodstream infections, how they affect the dialysis patient population and current treatments available:
CormedixMichael Allon, MD, University of Alabama Birmingham, Birmingham Alabama


©2011 CorMedix Inc.  

Site Map | Privacy Policy | Terms of Service